Utilizing Expertise & Experience for Successful Downstream Processing

Successful downstream processing provides isolation of the molecule of interest from extraneous constituents before formulation, allowing for favorable processing of the desired therapeutic or vaccine.

CDMOs that have the expertise and experience in optimizing downstream purification, filtration, and viral clearance processes for diverse and complex molecules can help their clients achieve positive processing outcomes.

Download our white paper to learn more about downstream processing methodologies and techniques, and how Emergent CDMO's vast expertise and experience can help you achieve your drug substance program goals.

DOWNLOAD WHITE PAPER

 

Vaxart AGREEMENT for Experimental Oral Vaccine Candidate for Coronavirus Disease

GAITHERSBURG, Md.,March 18, 2020(GLOBE NEWSWIRE) --Emergent BioSolutions Inc.(NYSE:EBS) announced today that it has entered...

READ MORE

Novavax agreement for Experimental Vaccine Candidate for Coronavirus Disease

GAITHERSBURG, Md.,March 10, 2020(GLOBE NEWSWIRE) --Emergent BioSolutions Inc.(NYSE:EBS) announced today that it has entered...

READ MORE

Emergent BioSolutions Signs Agreement with Novavax to Manufacture NanoFlu™

  • CDMO agreement for NanoFlu to support pathway to licensure
  • Expanded collaboration now includes NanoFlu and COVID-19 vaccine...
READ MORE